METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA — all Canadian products
15 DINs
0 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02308002 | MIRCERA | HOFFMANN-LA ROCHE LIMITED | Solution | Subcutaneous; Intravenous | METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA 100 MCG | Cancelled Pre Market | |
| 02308010 | MIRCERA | HOFFMANN-LA ROCHE LIMITED | Solution | Subcutaneous; Intravenous | METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA 200 MCG | Cancelled Pre Market | |
| 02308029 | MIRCERA | HOFFMANN-LA ROCHE LIMITED | Solution | Subcutaneous; Intravenous | METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA 300 MCG | Cancelled Pre Market | |
| 02308037 | MIRCERA | HOFFMANN-LA ROCHE LIMITED | Solution | Subcutaneous; Intravenous | METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA 400 MCG | Cancelled Pre Market | |
| 02308045 | MIRCERA | HOFFMANN-LA ROCHE LIMITED | Solution | Intravenous; Subcutaneous | METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA 600 MCG | Cancelled Pre Market | |
| 02308053 | MIRCERA | HOFFMANN-LA ROCHE LIMITED | Solution | Intravenous; Subcutaneous | METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA 1000 MCG | Cancelled Pre Market | |
| 02308061 | MIRCERA | HOFFMANN-LA ROCHE LIMITED | Solution | Subcutaneous; Intravenous | METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA 50 MCG | Cancelled Pre Market | |
| 02308088 | MIRCERA | HOFFMANN-LA ROCHE LIMITED | Solution | Intravenous; Subcutaneous | METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA 75 MCG | Cancelled Pre Market | |
| 02308118 | MIRCERA | HOFFMANN-LA ROCHE LIMITED | Solution | Intravenous; Subcutaneous | METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA 150 MCG | Cancelled Pre Market | |
| 02308126 | MIRCERA | HOFFMANN-LA ROCHE LIMITED | Solution | Intravenous; Subcutaneous | METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA 200 MCG | Cancelled Pre Market | |
| 02308134 | MIRCERA | HOFFMANN-LA ROCHE LIMITED | Solution | Intravenous; Subcutaneous | METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA 250 MCG | Cancelled Pre Market | |
| 02308142 | MIRCERA | HOFFMANN-LA ROCHE LIMITED | Solution | Intravenous; Subcutaneous | METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA 400 MCG | Cancelled Pre Market | |
| 02308150 | MIRCERA | HOFFMANN-LA ROCHE LIMITED | Solution | Subcutaneous; Intravenous | METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA 600 MCG | Cancelled Pre Market | |
| 02308096 | MIRCERA | HOFFMANN-LA ROCHE LIMITED | Solution | Intravenous; Subcutaneous | METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA 100 MCG | Cancelled Pre Market | |
| 02307995 | MIRCERA | HOFFMANN-LA ROCHE LIMITED | Solution | Subcutaneous; Intravenous | METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA 50 MCG | Cancelled Pre Market |
Browse other molecules: